Tenet Healthcare (THC) Tops Q2 EPS by 114c; offers guidance
Tweet
Share
E-mail
Get Alerts THC Hot Sheet
Price: $260.97 -0.39%
EPS Growth %: +25.1%
Financial Fact:
Income tax benefit (expense): -1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +25.1%
Financial Fact:
Income tax benefit (expense): -1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $4.02, $1.14 better than the analyst estimate of $2.88. Revenue for the quarter came in at $5.27 billion versus the consensus estimate of $5.16 billion.
GUIDANCE:
Tenet Healthcare sees FY2025 EPS of $15.55-$16.21, versus the consensus of $12.83. Tenet Healthcare sees FY2025 revenue of $20.95-21.25 million, versus the consensus of $20.92 million.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
- Paramount Skydance extends debt offer deadlines to October 2
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
